Hong Kong stocks fall on trade war and economic concerns
Press Hub UCapital
Share:
Hong Kong equities fell for the fourth consecutive session on Wednesday, pressured by ongoing trade tensions and skepticism surrounding China's ability to achieve its recently announced economic growth targets. The benchmark Hang Seng Index declined 0.77%, closing at 23,600.31, while the Hang Seng China Enterprises Index ended 0.84% lower at 8,682.13.
Investor sentiment remained cautious following China's recently concluded "Two Sessions," which outlined ambitious economic growth targets of approximately 5%. Analysts have expressed doubts about achieving these goals, despite new stimulus measures, including a significant 300 billion yuan rebate initiative for consumer spending on cars and appliances. Heightened trade tensions resulting from tariffs imposed by former U.S. President Donald Trump further exacerbated market uncertainty.
Adding to cautious investor sentiment, UBS downgraded China's technology sector from attractive to neutral, citing substantial gains already realized this year and limited additional upside.
In corporate developments, Kontafarma China Holdings experienced a sharp sell-off, plunging over 10% after projecting an increased net loss for 2024, potentially reaching HK$118.8 million compared to a HK$61.1 million loss in 2023. Conversely, the Hong Kong Exchange recognized its 20th foreign partner, welcoming a partnership with its 20th exchange, further opening international market access and diversification opportunities.
On balance, the Hong Kong market faces ongoing pressures from geopolitical uncertainties, particularly concerning trade tensions and economic policy effectiveness. Investors should closely track macroeconomic indicators and policy updates from China, as these will heavily influence near-term market trends and corporate performance.
Investor sentiment remained cautious following China's recently concluded "Two Sessions," which outlined ambitious economic growth targets of approximately 5%. Analysts have expressed doubts about achieving these goals, despite new stimulus measures, including a significant 300 billion yuan rebate initiative for consumer spending on cars and appliances. Heightened trade tensions resulting from tariffs imposed by former U.S. President Donald Trump further exacerbated market uncertainty.
Adding to cautious investor sentiment, UBS downgraded China's technology sector from attractive to neutral, citing substantial gains already realized this year and limited additional upside.
In corporate developments, Kontafarma China Holdings experienced a sharp sell-off, plunging over 10% after projecting an increased net loss for 2024, potentially reaching HK$118.8 million compared to a HK$61.1 million loss in 2023. Conversely, the Hong Kong Exchange recognized its 20th foreign partner, welcoming a partnership with its 20th exchange, further opening international market access and diversification opportunities.
On balance, the Hong Kong market faces ongoing pressures from geopolitical uncertainties, particularly concerning trade tensions and economic policy effectiveness. Investors should closely track macroeconomic indicators and policy updates from China, as these will heavily influence near-term market trends and corporate performance.